{"id":19228,"date":"2022-01-07T18:51:49","date_gmt":"2022-01-07T15:51:49","guid":{"rendered":"https:\/\/zdmaa.com\/what-is-her2-positive-breast-cancer\/"},"modified":"2022-01-07T21:00:04","modified_gmt":"2022-01-07T18:00:04","slug":"what-is-her2-positive-breast-cancer","status":"publish","type":"post","link":"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/","title":{"rendered":"HER2 pozitif meme kanseri nedir?"},"content":{"rendered":"<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span class=\"\" style=\"vertical-align: inherit;\">HER2 pozitif meme kanseri nedir?<\/span><\/span><\/span><\/span><\/p>\n<div>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Meme kanseri tek bir hastal\u0131k de\u011fil, her biri kendi genetik \u00f6zelliklerine sahip \u00e7e\u015fitli hastal\u0131klard\u0131r. <\/span><span style=\"vertical-align: inherit;\">Her molek\u00fcler alt tip, di\u011ferlerinden farkl\u0131 \u015fekilde ve farkl\u0131 sonu\u00e7larla tedavi edilir. <\/span><span style=\"vertical-align: inherit;\">Baz\u0131 meme kanserleri agresif ve \u00f6ng\u00f6r\u00fclemez olabilir; <\/span><span style=\"vertical-align: inherit;\">Di\u011ferleri biyolojik olarak daha az agresiftir.<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Klinisyenler, bu kanserleri s\u0131n\u0131fland\u0131rmak i\u00e7in meme kanseri h\u00fccreleri hakk\u0131ndaki genomik bilgileri giderek daha fazla kullan\u0131yor ve tipik olarak onlar\u0131 en az d\u00f6rt ana alt tipte s\u0131n\u0131fland\u0131r\u0131yor: l\u00fcmen A ve l\u00fcmen B, \u00fc\u00e7l\u00fc negatif ve insan epidermal b\u00fcy\u00fcme fakt\u00f6r\u00fc resept\u00f6r\u00fc 2 pozitif. <\/span><span style=\"vertical-align: inherit;\">(k\u0131saca HER2). <\/span><span style=\"vertical-align: inherit;\">Yakla\u015f\u0131k be\u015f meme kanserinden biri HER2 pozitiftir.<\/span><\/span><\/p>\n<h2><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">HER2 nedir?<\/span><\/span><\/h2>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">HER2, sa\u011fl\u0131kl\u0131 h\u00fccrelerde bulunan bir gendir, ancak mutasyona u\u011frad\u0131\u011f\u0131nda v\u00fccut, meme kanserine yol a\u00e7abilecek \u00e7ok fazla HER2 proteini \u00fcretir. <\/span><span class=\"\" style=\"vertical-align: inherit;\">HER-2 pozitif olsa bile bir kanserin kimyasal ve genetik yap\u0131s\u0131n\u0131 anlamak, doktorlar\u0131n spesifik tedavi \u00f6nermesine ve bir t\u00fcm\u00f6r yan\u0131t\u0131 olas\u0131l\u0131\u011f\u0131n\u0131 tahmin etmesine yard\u0131mc\u0131 olabilir. <\/span><span style=\"vertical-align: inherit;\">\u0130stilac\u0131 meme kanserleri genellikle bir hastane laboratuvar\u0131nda meme kanseri biyopsisi veya ameliyat\u0131 s\u0131ras\u0131nda al\u0131nan meme kanseri dokusu \u00f6rne\u011fi kullan\u0131larak HER2 seviyeleri i\u00e7in test edilir.<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Chicago Hastanesi&#8217;nde t\u0131bbi onkolog olan PhD, MB ChB, Dennis Citrine, &#8220;HER2-pozitif meme kanserleri karma\u015f\u0131kt\u0131r&#8221; diyor. <\/span><span style=\"vertical-align: inherit;\">&#8220;Di\u011fer meme kanseri t\u00fcrleriyle kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda, HER2 daha h\u0131zl\u0131 b\u00fcy\u00fcyor, biyolojik olarak daha agresif ve yay\u0131lma olas\u0131l\u0131\u011f\u0131 daha y\u00fcksek. Ancak art\u0131k HER2 proteinine sald\u0131rmak i\u00e7in tasarlanm\u0131\u015f ila\u00e7lar\u0131m\u0131z var. Herceptin\u00ae&#8217;in (trastuzumab) piyasaya s\u00fcr\u00fclmesi bir d\u00f6n\u00fcm noktas\u0131yd\u0131. Son 20 y\u0131lda meme kanseri tedavisindeki en \u00f6nemli ilerlemenin HER2&#8217;nin tan\u0131mlanmas\u0131 ve HER2&#8217;yi hedefleyen bir tedavinin geli\u015ftirilmesi oldu\u011funu d\u00fc\u015f\u00fcn\u00fcyorum.\u015eu anda HER2 pozitif meme kanseri i\u00e7in FDA onayl\u0131 be\u015f ilac\u0131m\u0131z var: trastuzumab, pertuzumab (Perjeta), lapatinib (Tykerb) ve ado-trastuzumab emtancin (Cadchila). ), ve neratinib (Nerlinx\u2122).<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Trastuzumab gibi ila\u00e7lara hedefe y\u00f6nelik tedaviler denir ve kanser h\u00fccrelerinin b\u00fcy\u00fcmesini ve yay\u0131lmas\u0131n\u0131 durdurmak i\u00e7in tasarlanm\u0131\u015ft\u0131r. <\/span><span style=\"vertical-align: inherit;\">Hedeflenen ila\u00e7lar genellikle farkl\u0131 yan etkilere sahiptir ve genellikle kemoterapiden daha az ciddidir. <\/span><span style=\"vertical-align: inherit;\">Dr. Citrine, &#8220;HER2 ila\u00e7lar\u0131 genellikle iyi tolere edilir ve genellikle sa\u00e7 d\u00f6k\u00fclmesine neden olmaz&#8221; diyor. <\/span><span style=\"vertical-align: inherit;\">&#8220;Fakat \u00f6nlem olarak, hedefe y\u00f6nelik tedavi ila\u00e7lar\u0131 alan hastalarda karaci\u011fer ve kalp fonksiyonlar\u0131n\u0131 izlemeliyiz.&#8221;<\/span><\/span><\/p>\n<h2><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">HER2 \u0627\u0644\u0625\u064a\u062c\u0627\u0628\u064a pozitif meme kanseri tedavisi<\/span><\/span><\/h2>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">HER2 pozitif meme kanserlerini tedavi etmek i\u00e7in baz\u0131 standart kemoterapi ila\u00e7lar\u0131 da kullan\u0131labilir, ancak bu ila\u00e7lar spesifik olarak HER2 proteinini hedeflemez. <\/span><span style=\"vertical-align: inherit;\">Baz\u0131 meme kanseri hastalar\u0131, HER2&#8217;yi hedefleyen mevcut tedavilerden fayda g\u00f6rmedi\u011finden ve di\u011ferleri belirli bir s\u00fcre tedaviden sonra diren\u00e7li hale geldi\u011finden, ara\u015ft\u0131rmac\u0131lar yeni veya modifiye edilmi\u015f ila\u00e7 kombinasyonlar\u0131n\u0131 test etmeye devam ediyor. <\/span><span style=\"vertical-align: inherit;\">Yan etkilere neden olmadan kanser h\u00fccrelerini \u00f6ld\u00fcrmek i\u00e7in tasarlanm\u0131\u015f ila\u00e7lar dahil.<\/span><\/span><\/p>\n<p><em><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">New England Journal of Medicine&#8217;de<\/span><\/span><\/em><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> yak\u0131n zamanda yay\u0131nlanan ara\u015ft\u0131rma <\/span><span style=\"vertical-align: inherit;\">, pertuzumab\u0131n, HER2 pozitif ameliyat edilebilir meme kanserli kad\u0131nlar i\u00e7in trastuzumab ve kemoterapi ile birlikte kullan\u0131ld\u0131\u011f\u0131nda sonu\u00e7lar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015ftirdi\u011fini buldu. <\/span><span style=\"vertical-align: inherit;\">Her iki ilac\u0131 birlikte alan hastalarda, tek ba\u015f\u0131na trastuzumab alanlara k\u0131yasla invaziv hastal\u0131\u011f\u0131n tekrarlama riski y\u00fczde 19 daha d\u00fc\u015f\u00fckt\u00fc. <\/span><span style=\"vertical-align: inherit;\">Her ikisi de farkl\u0131 b\u00f6lgelerde de olsa HER2 resept\u00f6r\u00fcne ba\u011fland\u0131\u011f\u0131ndan, pertuzumab ve trastuzumab\u0131n birbirini tamamlad\u0131\u011f\u0131na inan\u0131lmaktad\u0131r.<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Di\u011fer birka\u00e7 klinik \u00e7al\u0131\u015fma, HER2 pozitif meme kanseri i\u00e7in farkl\u0131 tedavi kombinasyonlar\u0131na bak\u0131yor. <\/span><span style=\"vertical-align: inherit;\">Baz\u0131 \u00e7al\u0131\u015fmalar ayr\u0131ca imm\u00fcnoterapinin meme kanserini tedavi etmek i\u00e7in umut verici bir se\u00e7enek olabilece\u011fini bulmu\u015ftur. <\/span><span style=\"vertical-align: inherit;\">Dr. Citrine, &#8220;Meme kanseri imm\u00fcnoterapisi aktif bir ara\u015ft\u0131rma alan\u0131d\u0131r&#8221; diyor. <\/span><span style=\"vertical-align: inherit;\">&#8220;\u0130mm\u00fcnoterapinin baz\u0131 meme kanseri t\u00fcrlerinin tedavisinde rol\u00fc olmas\u0131 \u00e7ok muhtemeldir.&#8221;<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>HER2 pozitif meme kanseri nedir? Meme kanseri tek bir hastal\u0131k de\u011fil, her biri kendi genetik \u00f6zelliklerine sahip \u00e7e\u015fitli hastal\u0131klard\u0131r. Her molek\u00fcler alt tip, di\u011ferlerinden farkl\u0131 \u015fekilde ve farkl\u0131 sonu\u00e7larla tedavi edilir. Baz\u0131 meme kanserleri agresif ve \u00f6ng\u00f6r\u00fclemez olabilir; Di\u011ferleri biyolojik olarak daha az agresiftir. Klinisyenler, bu kanserleri s\u0131n\u0131fland\u0131rmak i\u00e7in meme kanseri h\u00fccreleri hakk\u0131ndaki genomik bilgileri &hellip;<\/p>\n","protected":false},"author":1,"featured_media":19098,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-19228","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-tr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>HER2 pozitif meme kanseri nedir? - zdmaa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HER2 pozitif meme kanseri nedir? - zdmaa\" \/>\n<meta property=\"og:description\" content=\"HER2 pozitif meme kanseri nedir? Meme kanseri tek bir hastal\u0131k de\u011fil, her biri kendi genetik \u00f6zelliklerine sahip \u00e7e\u015fitli hastal\u0131klard\u0131r. Her molek\u00fcler alt tip, di\u011ferlerinden farkl\u0131 \u015fekilde ve farkl\u0131 sonu\u00e7larla tedavi edilir. Baz\u0131 meme kanserleri agresif ve \u00f6ng\u00f6r\u00fclemez olabilir; Di\u011ferleri biyolojik olarak daha az agresiftir. Klinisyenler, bu kanserleri s\u0131n\u0131fland\u0131rmak i\u00e7in meme kanseri h\u00fccreleri hakk\u0131ndaki genomik bilgileri &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"zdmaa\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-07T15:51:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-07T18:00:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/breast-feeding-g2dfb745e4_640.png\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/\",\"url\":\"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/\",\"name\":\"HER2 pozitif meme kanseri nedir? - zdmaa\",\"isPartOf\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/breast-feeding-g2dfb745e4_640.png\",\"datePublished\":\"2022-01-07T15:51:49+00:00\",\"dateModified\":\"2022-01-07T18:00:04+00:00\",\"author\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3\"},\"breadcrumb\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/#primaryimage\",\"url\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/breast-feeding-g2dfb745e4_640.png\",\"contentUrl\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/breast-feeding-g2dfb745e4_640.png\",\"width\":640,\"height\":600,\"caption\":\"What is HER2-positive breast cancer?\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\/\/zdmaa.com\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HER2 pozitif meme kanseri nedir?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#website\",\"url\":\"https:\/\/zdmaa.com\/tr\/ro\/\",\"name\":\"zdmaa\",\"description\":\"zdmaa\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/zdmaa.com\/tr\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775349884\",\"contentUrl\":\"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775349884\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/zdmaa.com\"],\"url\":\"https:\/\/zdmaa.com\/tr\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HER2 pozitif meme kanseri nedir? - zdmaa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/","og_locale":"tr_TR","og_type":"article","og_title":"HER2 pozitif meme kanseri nedir? - zdmaa","og_description":"HER2 pozitif meme kanseri nedir? Meme kanseri tek bir hastal\u0131k de\u011fil, her biri kendi genetik \u00f6zelliklerine sahip \u00e7e\u015fitli hastal\u0131klard\u0131r. Her molek\u00fcler alt tip, di\u011ferlerinden farkl\u0131 \u015fekilde ve farkl\u0131 sonu\u00e7larla tedavi edilir. Baz\u0131 meme kanserleri agresif ve \u00f6ng\u00f6r\u00fclemez olabilir; Di\u011ferleri biyolojik olarak daha az agresiftir. Klinisyenler, bu kanserleri s\u0131n\u0131fland\u0131rmak i\u00e7in meme kanseri h\u00fccreleri hakk\u0131ndaki genomik bilgileri &hellip;","og_url":"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/","og_site_name":"zdmaa","article_published_time":"2022-01-07T15:51:49+00:00","article_modified_time":"2022-01-07T18:00:04+00:00","og_image":[{"width":640,"height":600,"url":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/breast-feeding-g2dfb745e4_640.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"admin","Tahmini okuma s\u00fcresi":"3 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/","url":"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/","name":"HER2 pozitif meme kanseri nedir? - zdmaa","isPartOf":{"@id":"https:\/\/zdmaa.com\/tr\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/breast-feeding-g2dfb745e4_640.png","datePublished":"2022-01-07T15:51:49+00:00","dateModified":"2022-01-07T18:00:04+00:00","author":{"@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3"},"breadcrumb":{"@id":"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/#primaryimage","url":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/breast-feeding-g2dfb745e4_640.png","contentUrl":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/breast-feeding-g2dfb745e4_640.png","width":640,"height":600,"caption":"What is HER2-positive breast cancer?"},{"@type":"BreadcrumbList","@id":"https:\/\/zdmaa.com\/tr\/what-is-her2-positive-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/zdmaa.com\/tr\/"},{"@type":"ListItem","position":2,"name":"HER2 pozitif meme kanseri nedir?"}]},{"@type":"WebSite","@id":"https:\/\/zdmaa.com\/tr\/ro\/#website","url":"https:\/\/zdmaa.com\/tr\/ro\/","name":"zdmaa","description":"zdmaa","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/zdmaa.com\/tr\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3","name":"admin","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/image\/","url":"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775349884","contentUrl":"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775349884","caption":"admin"},"sameAs":["https:\/\/zdmaa.com"],"url":"https:\/\/zdmaa.com\/tr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/19228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/comments?post=19228"}],"version-history":[{"count":2,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/19228\/revisions"}],"predecessor-version":[{"id":19247,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/19228\/revisions\/19247"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/media\/19098"}],"wp:attachment":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/media?parent=19228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/categories?post=19228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/tags?post=19228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}